Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.

Academic Article

Authors

Published In

Keywords

  • Alendronate, Antibodies, Monoclonal, Bone Density, Bone Density Conservation Agents, Female, Fractures, Bone, Humans, Osteoporosis, Osteoporosis, Postmenopausal
  • Digital Object Identifier (doi)

    Author List

  • Saag KG; Petersen J; Grauer A
  • Start Page

  • 195
  • End Page

  • 196
  • Volume

  • 378
  • Issue

  • 2